Antidepressant treatment and risk of dementia: A population-based, retrospective case-control study

Journal of Clinical Psychiatry

Volumn 77, Issue 1, 2016, Pages 117-122

  Lee, Cynthia Wei Sheng ^a,b   Lin, Cheng Li ^a,b   Sung, Fung Chang ^c   Liang, Ji An ^a,c   Kao, Chia Hung ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HETEROCYCLIC COMPOUND; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; HEAD INJURY; HUMAN; HYPERTENSION; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; NATIONAL HEALTH INSURANCE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; TAIWAN; CHEMICALLY INDUCED; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; FACTUAL DATABASE; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DEMENTIA; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84957802204     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09580     Document Type: Article

References (22)

1. van der Flier WM, Scheltens P. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry. 2005;76(suppl 5):v2-v7. doi:10.136/jnp. 205.082867 PubMed
2. Wu YT, Lee HY, Norton S, et al. Prevalence studies of dementia in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. PLoS ONE. 2013;8(6):e66252. doi:10.1371/journal.pone.06252 PubMed
3. Ferri CP, Prince M, Brayne C, et al; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112-2117. doi:10.1016/S0140-6736 (05) 6789-0 PubMed
4. da Silva J, Gonçalves-Pereira M, Xavier M, et al. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013;202(3):177-186. doi:10.192/bjp. bp. 1.101931 PubMed
5. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323-331. doi:10.1038/nrneurol.201.60 PubMed
6. Caraci F, Copani A, Nicoletti F, et al. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol. 2010;626(1):64-71. doi:10.1016/j.ejphar.209.10.02 PubMed
7. Dotson VM, Beydoun MA, Zonderman AB. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology. 2010;75(1):27-34. doi:10.1212/WNL.0b013e3181e62124 PubMed
8. Goveas JS, Espeland MA, Woods NF, et al. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study. J Am Geriatr Soc. 2011;59(1):57-66. doi:10.1/j.1532-5415.2010.0323.x PubMed
9. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry. 2001;35(6):776-781. doi:10.1046/j.140-1614.201.0967.x PubMed
10. Kessing LV. Depression and the risk for dementia. Curr Opin Psychiatry. 2012;25(6):457-461. doi:10.1097/YCO.0b013e328356c368 PubMed
11. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord. 2003;73(3):261-269. doi:10.1016/S0165-0327 (02) 04-6 PubMed
12. Lenoir H, Dufouil C, Auriacombe S, et al. Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis. 2011;26(1):27-38.
13. Li G, Wang LY, Shofer JB, et al. Temporal relationship between depression and dementia: findings from a large communitybased 15-year follow-up study. Arch Gen Psychiatry. 2011;68(9):970-977. doi:10.101/archgenpsychiatry.201.86 PubMed
14. Ownby RL, Crocco E, Acevedo A, et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530-538. doi:10.101/archpsyc.63.5.530 PubMed
15. Aznar S, Knudsen GM. Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? J Alzheimers Dis. 2011;23(2):177-193.
16. Barnes DE, Yaffe K, Byers AL, et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012;69(5):493-498. doi:10.101/archgenpsychiatry.201.1481 PubMed
17. Kessing LV, Søndergård L, Forman JL, et al. Antidepressants and dementia. J Affect Disord. 2009;117(1-2):24-29. doi:10.1016/j.jad.208.1.020 PubMed
18. Cheng TM. Taiwan's National Health Insurance System: High Value for the Dollar. In: Okma KGH, Crivelli L, eds. Six Countries, Six Reform Models: The Healthcare Reform: Experience of Israel, The Netherlands, New Zealand, Singapore, Switzerland and Taiwan. Singapore: World Scientific Publishing Co; 2010:171-204.
19. Kessing LV, Forman JL, Andersen PK. Do continued antidepressants protect against dementia in patients with severe depressive disorder? Int Clin Psychopharmacol. 2011;26(6):316-322. doi:10.1097/YIC.0b013e32834ace0f PubMed
20. Hwang J, Zheng LT, Ock J, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology. 2008;55(5):826-834. doi:10.1016/j.neuropharm.208.06.045 PubMed
21. Chavant F, Deguil J, Pain S, et al. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 2010;332(2):505-514. doi:10.124/jpet.109.162164 PubMed
22. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236-242. doi:10.102/pds.2087